Michael Kolber
Gründer bei Siesta Medical, Inc.
Profil
Michael Kolber is the founder of Siesta Medical, Inc. founded in 2009, where he holds the title of VP-Regulatory Affairs & Clinical Research.
He held the position of Vice President-Regulatory Affairs at Paracor Medical, Inc. from 2003 to 2011.
Prior to that, he was the VP-Regulatory Affairs & Quality Assurance at Appriva Medical, Inc. from 2000 to 2003.
He also held the position of Vice President-Clinical & Regulatory Affairs at BioCardia, Inc. and VP-Regulatory Affairs & Quality Assurance at Prograft Medical, Inc. Mr. Kolber has a graduate degree from the University of California, Los Angeles, an undergraduate degree from San Diego State University, and an MBA from the College of Saint Mary.
Aktive Positionen von Michael Kolber
| Unternehmen | Position | Beginn |
|---|---|---|
Siesta Medical, Inc.
 Siesta Medical, Inc. Medical SpecialtiesHealth Technology Siesta Medical, Inc. develops surgical implants and tools for the treatment of obstructive sleep apnea. It offers airlift procedure that include hyoid and tongue suspension. The Company was founded by Peter Martin, Erik van der Burg, Chris Feezor and Michael Kolber in 2009 and is headquartered in Los Gatos, CA. | Gründer | 01.01.2009 |
Ehemalige bekannte Positionen von Michael Kolber
| Unternehmen | Position | Ende |
|---|---|---|
Appriva Medical, Inc.
 Appriva Medical, Inc. Medical SpecialtiesHealth Technology Appriva Medical, Inc. designs, develops and manufactures medical devices. The firm's products include manufacturing of closed-chest, catheter-based device for occluding the left atrial appendage and PLAATO. The company was founded by Dr. Lesh and Erik van der Burg in 1998 and is headquartered in Sunnyvale, CA | General Counsel | 01.03.2003 |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | General Counsel | - |
| Prograft Medical, Inc. | General Counsel | - |
Paracor Medical, Inc.
 Paracor Medical, Inc. Medical SpecialtiesHealth Technology Paracor Medical, Inc. develops medical devices for treatment and prevention of congestive heart failure. The firm offers HeartNet Ventricular Support System, a super-elastic Nitinol mesh. The company was founded in 1999 and is headquartered in Sunnyvale, CA. | General Counsel | - |
Ausbildung von Michael Kolber
| San Diego State University | Undergraduate Degree |
| University of California, Los Angeles | Graduate Degree |
| College of Saint Mary | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Paracor Medical, Inc.
Paracor Medical, Inc. Medical SpecialtiesHealth Technology Paracor Medical, Inc. develops medical devices for treatment and prevention of congestive heart failure. The firm offers HeartNet Ventricular Support System, a super-elastic Nitinol mesh. The company was founded in 1999 and is headquartered in Sunnyvale, CA. | Health Technology |
Appriva Medical, Inc.
Appriva Medical, Inc. Medical SpecialtiesHealth Technology Appriva Medical, Inc. designs, develops and manufactures medical devices. The firm's products include manufacturing of closed-chest, catheter-based device for occluding the left atrial appendage and PLAATO. The company was founded by Dr. Lesh and Erik van der Burg in 1998 and is headquartered in Sunnyvale, CA | Health Technology |
Siesta Medical, Inc.
Siesta Medical, Inc. Medical SpecialtiesHealth Technology Siesta Medical, Inc. develops surgical implants and tools for the treatment of obstructive sleep apnea. It offers airlift procedure that include hyoid and tongue suspension. The Company was founded by Peter Martin, Erik van der Burg, Chris Feezor and Michael Kolber in 2009 and is headquartered in Los Gatos, CA. | Health Technology |
| Prograft Medical, Inc. | |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
